Mobile navigation menu modal
Learn more about what our experts think about topical subjects.
When bringing cell and gene therapies (CGTs) to market, developers must successfully navigate various obstacles, including the technical aspects of...
Emerging biotechs often face unique challenges compared to larger, more traditional pharmaceutical companies.
A global narrative was required to tell the scientific story for a client launching a new class of multiple sclerosis monoclonal antibody treatment.
